Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 9Unknown 7Recruiting 6Active not recruiting 6Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Breast 2Thoracic 1Other solid neoplasm 1Gynecologic 1

Conditions

Breast Neoplasms 2

Interventions

Trastuzumab 25Carboplatin 20Paclitaxel 19pertuzumab 18pyrotinib 17Cyclophosphamide 17Capecitabine 16trastuzumab deruxtecan 15Docetaxel 15Radiotherapy 13Standard of Care 12Fulvestrant 12Drug Therapy 12dalpiciclib 11Letrozole 11pembrolizumab 9Epirubicin 9sacituzumab govitecan 8palbociclib 8exemestane 8eribulin 8Anastrozole 8Injections 7Doxorubicin 7130-nm albumin-bound paclitaxel 7toripalimab 6abemaciclib 6Tamoxifen 6Specimen Handling 6Neoadjuvant Therapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Radiation Dose Hypofractionation × Breast × Clear all
NCT07084519 2025-07-24

Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Not yet recruiting
190 enrolled
Breast

Breast Neoplasms

NCT05253170 2022-03-11

Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients

Seoul National University Bundang Hospital

Phase 3 Not yet recruiting
622 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡